Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
35
ALT Quote, Financials, Valuation and Earnings
Last price:
$5.61
Seasonality move
:
-9.61%
Day range:
$5.45 - $6.01
52-week range:
$5.14 - $11.16
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
21,196.69x
P/B ratio:
3.72x
Volume:
5.9M
Avg. volume:
2.9M
1-year change:
-39.45%
Market cap:
$459.8M
Revenue:
$20K
EPS (TTM):
-$1.34
ALT Analysts' Consensus Rating
The 7 analysts providing 12-month price projections for Altimmune shares anticipate an average target of $22.38, ranging from a low estimate of $12.00 to a high estimate of $28.00. This average target implies a growth of 274.79% compared to the current stock price of $5.97.
Consensus Price Target
$22.38
Highest Price Target
$28.00
Lowest Price Target
$12.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 3 | 5 | 5 |
| Hold | 2 | 1 | 2 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
ALT Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
